PB1986: FIRST-LINE TREATMENT OUTCOMES OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IN A REAL-WORLD DATA SETTING IN LEBANON

por Nasr, Lewis, Diab, Saada, Yehia, Intissar, Nasr, Fadi
Publicado 2023

PB1896: ACUTE MYELOID LEUKEMIA (AML): REAL-WORLD DATA FROM LEBANON

por Nasr, Lewis, Diab, Saada, Yehia, Intissar, Nasr, Fadi
Publicado 2023

PB1950: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): REAL-WORLD DATA FROM LEBANON

por Nasr, Lewis, Haydamous, Joe, Yehia, Intissar, Diab, Saada, Nasr, Fadi
Publicado 2023

Central Nervous System Prophylaxis and Treatment in Acute Leukemias

por Wu, Susan Y., Short, Nicholas J., Nasr, Lewis, Dabaja, Bouthaina S., Fang, Penny Q.
Publicado 2022

Negativation of PD-L1 Postoperatively in Initially Inoperable Stage III Non-Small Cell Lung Cancer Treated with Pembrolizumab: Two Case Reports

por Nasr, Fadi, Al Ghoche, Ahmad, Eid, Roland, Nasr, Lewis, Diab, Saada, Hallit, Souheil, Riachi, Moussa
Publicado 2019

Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective Study

por Nasr, Fadi, Ghoche, Ahmad Al, Diab, Saada, Nasr, Lewis, Ammanouil, Emmanuel, Riachy, Christelle, Hallit, Souheil, Chahine, Georges
Publicado 2021

Adhesion molecules in multiple myeloma oncogenesis and targeted therapy

por Bou Zerdan, Maroun, Nasr, Lewis, Kassab, Joseph, Saba, Ludovic, Ghossein, Myriam, Yaghi, Marita, Dominguez, Barbara, Chaulagain, Chakra P
Publicado 2022

A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology

por Bou Zerdan, Maroun, Nasr, Lewis, Saba, Ludovic, Meouchy, Paul, Safi, Nadine, Allam, Sabine, Bhandari, Jenish, Chaulagain, Chakra P.
Publicado 2022

AI-based online chat and the future of oncology care: a promising technology or a solution in search of a problem?

por Kassab, Joseph, Nasr, Lewis, Gebrael, Georges, Chedid El Helou, Michel, Saba, Ludovic, Haroun, Elio, Dahdah, Joseph El, Nasr, Fadi
Publicado 2023

Systemic AL amyloidosis: current approach and future direction

por Bou Zerdan, Maroun, Nasr, Lewis, Khalid, Farhan, Allam, Sabine, Bouferraa, Youssef, Batool, Saba, Tayyeb, Muhammad, Adroja, Shubham, Mammadii, Mahinbanu, Anwer, Faiz, Raza, Shahzad, Chaulagain, Chakra P.
Publicado 2023

Liquid biopsies and minimal residual disease in lymphoid malignancies

por Bou Zerdan, Maroun, Kassab, Joseph, Saba, Ludovic, Haroun, Elio, Bou Zerdan, Morgan, Allam, Sabine, Nasr, Lewis, Macaron, Walid, Mammadli, Mahinbanu, Abou Moussa, Sarah, Chaulagain, Chakra P.
Publicado 2023

Addendum: Systemic AL amyloidosis: current approach and future direction

por Bou Zerdan, Maroun, Nasr, Lewis, Khalid, Farhan, Allam, Sabine, Bouferraa, Youssef, Batool, Saba, Tayyeb, Muhammad, Adroja, Shubham, Mammadii, Mahinbanu, Anwer, Faiz, Raza, Shahzad, Chaulagain, Chakra P.
Publicado 2023

P358: HYPER-CVAD WITH BLINATUMOMAB AND INOTUZUMAB OZOGAMICIN FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE II STUD...

por Short, Nicholas, Jabbour, Elias, Jain, Nitin, Haddad, Fadi, Yilmaz, Musa, Nasr, Lewis, Ferrajoli, Alessandra, Kadia, Tapan, Alvarado, Yesid, Maiti, Abhishek, Macaron, Walid, Zoghbi, Marianne, Nasnas, Cedric, Garris, Rebecca, Zhao, Min, Konopleva, Marina, Ravandi, Farhad, Kantarjian, Hagop
Publicado 2023

S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYS...

por Short, Nicholas, Jabbour, Elias, Jain, Nitin, Huang, Xuelin, Macaron, Walid, Nasr, Lewis, Montalban-Bravo, Guillermo, Kadia, Tapan, Daver, Naval, Chien, Kelly, Alvarado, Yesid, Issa, Ghayas, Haddad, Fadi, Nasnas, Cedric, Zoghbi, Marianne, Garris, Rebecca, Konopleva, Marina, Ravandi, Farhad, Kantarjian, Hagop
Publicado 2023

P364: A PHASE II STUDY OF LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AND PONATINIB FOLLOWED BY BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE L...

por Haddad, Fadi, Jabbour, Elias, Nasr, Lewis, Short, Nicholas, Macaron, Walid, Nasnas, Cedric, Zoghbi, Marianne, Issa, Ghayas, Yilmaz, Musa, Daver, Naval, Pemmaraju, Naveen, Masarova, Lucia, Ravandi, Farhad, Jain, Nitin, Deen, Wuliamatu, Loiselle, Christopher, Waller, Lourdes, Banks, Glenda, Garris, Rebecca, Kantarjian, Hagop
Publicado 2023

P373: UPDATES FROM A PHASE II TRIAL OF MINI-HYPER-CVD-INOTUZUMAB WITH OR WITHOUT BLINATUMOMAB IN OLDER PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYM...

por Haddad, Fadi, Jabbour, Elias, Nasnas, Cedric, Short, Nicholas, Nasr, Lewis, Macaron, Walid, Zoghbi, Marianne, Ravandi, Farhad, Jain, Nitin, Kadia, Tapan, Daver, Naval, Borthakur, Gautam, Dinardo, Courtney, Jacob, Jovitta, Roy, Edith, Loiselle, Christopher, Milton, Anna, Rivera, Juan, Garris, Rebecca, Kantarjian, Hagop
Publicado 2023

S119: COMBINATION OF MINI-HYPER-CVD AND INOTUZUMAB (INO) FOLLOWED BY BLINATUMOMAB (BLINA) CONSOLIDATION IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL...

por Haddad, Fadi, Jabbour, Elias, Nasnas, Cedric, Short, Nicholas, Macaron, Walid, Zoghbi, Marianne, Nasr, Lewis, Jain, Nitin, Almanza, Emmanuel, Sasaki, Koji, Ravandi, Farhad, Kebriaei, Partow, Huang, Xuelin, Garcia-Manero, Guillermo, Kadia, Tapan, Wang, Sa, Jacob, Jovitta, Garris, Rebecca, O’brien, Susan, Kantarjian, Hagop
Publicado 2023

P377: A PHASE II TRIAL OF MINI-HYPER-CVD WITH VENETOCLAX FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) PHILADELPHIA CHROMOSOME (PH)-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

por Haddad, Fadi, Jabbour, Elias, Zoghbi, Marianne, Short, Nicholas, Senapati, Jayastu, Macaron, Walid, Nasnas, Cedric, Nasr, Lewis, Pemmaraju, Naveen, Jain, Nitin, Wierda, William G., Borthakur, Gautam, Montalban-Bravo, Guillermo, Ravandi, Farhad, Garcia-Manero, Guillermo, Kadia, Tapan, Chien, Kelly, Thankachan, Jennifer, Garris, Rebecca, Kantarjian, Hagop
Publicado 2023

P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A SUBGROUP ANALYSIS FROM A PHASE II STUDY

por Short, Nicholas, Macaron, Walid, Dinardo, Courtney, Daver, Naval, Yilmaz, Musa, Borthakur, Gautam, Montalban-Bravo, Guillermo, Garcia-Manero, Guillermo, Issa, Ghayas, Sasaki, Koji, Burger, Jan, Maiti, Abhishek, Alvarado, Yesid, Thankachan, Jennifer, Abramova, Regina, Nasr, Lewis, Nasnas, Cedric, Zoghbi, Marianne, Kadia, Tapan, Konopleva, Marina, Kantarjian, Hagop, Ravandi, Farhad
Publicado 2023

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

por Short, Nicholas J., Muftuoglu, Muharrem, Ong, Faustine, Nasr, Lewis, Macaron, Walid, Montalban-Bravo, Guillermo, Alvarado, Yesid, Basyal, Mahesh, Daver, Naval, Dinardo, Courtney D., Borthakur, Gautam, Jain, Nitin, Ohanian, Maro, Jabbour, Elias, Issa, Ghayas C., Qiao, Wei, Huang, Xuelin, Kanagal-Shamanna, Rashmi, Patel, Keyur P., Bose, Prithviraj, Ravandi, Farhad, Delumpa, Ricardo, Abramova, Regina, Garcia-Manero, Guillermo, Andreeff, Michael, Cortes, Jorge, Kantarjian, Hagop
Publicado 2023